News
Pfizer CEO Albert Bourla is expected at a pro-Trump fundraiser on Friday, sources told CBS News, one day after the president ...
Vinay Prasad’s ouster as the Food and Drug Administration’s top vaccine and gene therapy regulator came after frustration ...
A logistics firm near downtown Cincinnati is relocating its offices to Blue Ash following a string of violent incidents in ...
AstraZeneca’s CEO said the company has proposed U.S. price cuts to some drugs, while Doximity enters competitive AI scribing ...
The Food and Drug Administration has approved a vagus nerve bioimplant to treat rheumatoid arthritis (RA). The scientific ...
President Donald Trump called out 17 Big Pharma CEOs over "exorbitant" drug pricing in individual letters sent out Thursday, ...
Vicarious Surgical (NYSE:RBOT) announced today that it appointed Stephen From as CEO, effective Aug. 7, 2025. Adam Sachs, ...
4d
MedPage Today on MSNNew FDA Drug Chief: 'Revolving Door' or Reformer?
The founder and former CEO of several pharmaceutical companies, Tidmarsh was tapped by FDA Commissioner Marty Makary, MD, MPH ...
Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing ...
Novo Nordisk tapped Maziar Mike Doustdar, its head of international operations, as its new chief executive officer and ...
Insightec, the Miami-based innovator in focused ultrasound to transform patient care, announced July 8 the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results